Understanding The Role Of Sex Hormones In Mental Illness
Funder
National Health and Medical Research Council
Funding Amount
$419,180.00
Summary
Evidence suggests that the female hormone, estrogen, protects against schizophrenia, although the exact mechanism of action underlying this effect is unclear. We believe that by measuring estrogen-induced changes in the levels of genes in the brain, we will identify the way that estrogens protect against the symptoms of schizophrenia and improve antipsychotic treatment response.
Regenerative Neuroscience Strategies For Brain Ageing And Dementia
Funder
National Health and Medical Research Council
Funding Amount
$426,079.00
Summary
Dementia is the pre-eminent medical challenge of our times as it affects 34 million individuals and will quadruple by 2050. This research therefore aims to develop new preventative and therapeutic strategies for dementia. Seven different studies are proposed, ranging from new stem-cell treatments for testing in rodents, to human clinical trials looking at the preventative effects of physical and mental exercise. These are linked by a central idea of boosting the brain’s neuroplasticity.
The extraordinary virulence of malaria parasites is in part due to their ability to export hundreds of proteins into their host cell to obtain nutrients and avoid the immune system. Recently the investigator has discovered the machinery that provides the gateway for these proteins to enter the host cell. She now aims to characterise this machinery and dissect its functional significance in vivo, so that strategies that block this crucial process can be developed to kill the parasite.
Functional Genomics-new Technologies For Gene Discovery And Personalised Medicine
Funder
National Health and Medical Research Council
Funding Amount
$452,122.00
Summary
Disorders of the brain, which affect people of all ages, are one of the largest health, economic and social burdens in the developed world. These conditions are chronic, debilitating and have limited symptomatic treatments available. In general, very little is known about the causes of many brain disorders. This project aims to identify the genes and mechanisms that underlie these diseases to enable the development of diagnostic and treatment programs to help reduce the incidence and severity of ....Disorders of the brain, which affect people of all ages, are one of the largest health, economic and social burdens in the developed world. These conditions are chronic, debilitating and have limited symptomatic treatments available. In general, very little is known about the causes of many brain disorders. This project aims to identify the genes and mechanisms that underlie these diseases to enable the development of diagnostic and treatment programs to help reduce the incidence and severity of disease.Read moreRead less
A New Paradigm To Prevent Intracranial Hypertension
Funder
National Health and Medical Research Council
Funding Amount
$408,388.00
Summary
Increasing brain pressure after stroke or other forms of brain injury can cause further injury and death. Body cooling by 4-5 0C (hypothermia) for 12-24 hours saves lives after some forms of brain injury, but may have major side effects. We found that 2 hour hypothermia has a long-lasting effect preventing pressure elevation. We will determine the best temperature and duration of hypothermia in a stroke model and use imaging to confirm findings in patients, with a view to later human trials.
My research is focused on understanding the aetiology of brain disorders. I am interested in the interaction of genetic and environmental factors in the development of these disorders. In particular, I will evaluate the validity of rodent models for schizophrenia and Alzheimer’s disease and investigate the therapeutic potential of the endocannabinoid system for both disorders and whether environmental enrichment (e.g. physical exercise) can have beneficial effects in these models.
Monoclonal antibodies, such as the breast cancer therapeutic Herceptin, have revolutionised the treatment of cancer and inflammatory conditions. Will over $30 billion sales in 2011, they have also spawned a growing biotech industry. We have a generated a highly specific monoclonal antibody, which has shown efficacy in models of disease. This project will further advance and develop this monoclonal, allowing us to initiate clinical studies in patients.
The Emergence Of Dead Enzymes As Signal Transducers And Therapeutic Targets
Funder
National Health and Medical Research Council
Funding Amount
$463,652.00
Summary
The cells within our bodies are constantly being replenished by new cells. Removal of old cells is typically fast and without fanfare. However, in some cases, cell death can be used to evoke an inflammatory response. My work examines the molecular details of how this happens and how we might advance our knowledge to develop novel drugs to prevent inflammatory diseases, such as Crohn's disease and psoriasis.
The Role Of CD1-restricted T Cells In Health And Disease
Funder
National Health and Medical Research Council
Funding Amount
$431,000.00
Summary
The human immune system requires T cells for survival. Specialised populations of T cells exist that patrol the body and target unwanted lipid molecules expressed by bacteria or by cells that have become abnormal or cancerous. I will identify these T cells in human blood and skin and determine their role in protection against disease. I will explore the types of lipids molecules recognised by these T cells and use this information to help prevent human diseases.